Step‐by‐step diagnosis and management of the nocebo/drucebo effect in statin‐associated muscle symptoms patients: a position paper from the International Lipid Expert Panel (ILEP)
Published 2022 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Step‐by‐step diagnosis and management of the nocebo/drucebo effect in statin‐associated muscle symptoms patients: a position paper from
the International Lipid Expert Panel
(ILEP)
Authors
Keywords
-
Journal
Journal of Cachexia Sarcopenia and Muscle
Volume -, Issue -, Pages -
Publisher
Wiley
Online
2022-03-11
DOI
10.1002/jcsm.12960
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Prevalence of statin intolerance: a meta-analysis
- (2022) Ibadete Bytyçi et al. EUROPEAN HEART JOURNAL
- Drucebo effect – the challenge we should all definitely face!
- (2021) Maciej Banach et al. Archives of Medical Science
- Lipid-lowering therapies: Better together
- (2021) Maciej Banach et al. ATHEROSCLEROSIS
- The neuropsychology of statin intolerance
- (2021) Jennifer G. Robinson Nature Reviews Cardiology
- Response to “Drucebo effect – the challenge we should all definitely face!”
- (2021) James Howard et al. Archives of Medical Science
- Pooled Patient-Level Analysis of Inclisiran Trials in Patients With Familial Hypercholesterolemia or Atherosclerosis
- (2021) R. Scott Wright et al. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY
- Novel Therapeutical Approaches to Managing Atherosclerotic Risk
- (2021) Rosaria Vincenza Giglio et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- Optimal use of lipid-lowering therapy after acute coronary syndromes: A Position Paper endorsed by the International Lipid Expert Panel (ILEP)
- (2021) Maciej Banach et al. PHARMACOLOGICAL RESEARCH
- Risk-factors associated with extremely high cardiovascular risk of mid- and long-term mortality following myocardial infarction: Analysis of the Hyperlipidaemia Therapy in tERtiary Cardiological cEnTer (TERCET) registry
- (2021) Krzysztof Dyrbuś et al. ATHEROSCLEROSIS
- Nocebo/drucebo effect in statin-intolerant patients: an attempt at recommendations
- (2021) Peter E Penson et al. EUROPEAN HEART JOURNAL
- Impact of nutraceuticals on markers of systemic inflammation: Potential relevance to cardiovascular diseases – A position paper from the International Lipid Expert Panel (ILEP)
- (2021) Massimiliano Ruscica et al. PROGRESS IN CARDIOVASCULAR DISEASES
- Intensity of statin therapy and muscle symptoms: a network meta-analysis of 153 000 patients
- (2021) John W Davis et al. BMJ Open
- PoLA/CFPiP/PCS/PSLD/PSD/PSH guidelines on diagnosis and therapy of lipid disorders in Poland 2021
- (2021) Maciej Banach et al. Archives of Medical Science
- Effect of Long-Term Marine ɷ-3 Fatty Acids Supplementation on the Risk of Atrial Fibrillation in Randomized Controlled Trials of Cardiovascular Outcomes: A Systematic Review and Meta-Analysis
- (2021) Baris Gencer et al. CIRCULATION
- How I treat statin-associated side effects in an outpatient setting
- (2021) Vishnu Priya Pulipati et al. Future Cardiology
- A systematic review of factors associated with side-effect expectations from medical interventions
- (2020) Louise E. Smith et al. HEALTH EXPECTATIONS
- Brief recommendations on the management of adult patients with familial hypercholesterolemia during the COVID-19 pandemic
- (2020) Maciej Banach et al. PHARMACOLOGICAL RESEARCH
- Association of Bempedoic Acid Administration With Atherogenic Lipid Levels in Phase 3 Randomized Clinical Trials of Patients With Hypercholesterolemia
- (2020) Maciej Banach et al. JAMA Cardiology
- LDL-C: lower is better for longer—even at low risk
- (2020) Peter E. Penson et al. BMC Medicine
- The Role of Nutraceuticals in the Optimization of Lipid-Lowering Therapy in High-Risk Patients with Dyslipidaemia
- (2020) Peter E. Penson et al. Current Atherosclerosis Reports
- An update on PCSK9 inhibitors- pharmacokinetics, drug interactions, and toxicity
- (2020) Svetlana Moşteoru et al. Expert Opinion on Drug Metabolism & Toxicology
- Natural compounds as anti-atherogenic agents: Clinical evidence for improved cardiovascular outcomes
- (2020) Peter E. Penson et al. ATHEROSCLEROSIS
- Reported muscle symptoms during statin treatment amongst Italian dyslipidaemic patients in the real‐life setting: the PROSISA Study
- (2020) M. Casula et al. JOURNAL OF INTERNAL MEDICINE
- N-of-1 Trial of a Statin, Placebo, or No Treatment to Assess Side Effects
- (2020) Frances A. Wood et al. NEW ENGLAND JOURNAL OF MEDICINE
- How much should LDL cholesterol be lowered in secondary prevention? Clinical efficacy and safety in the era of PCSK9 inhibitors
- (2020) Barbara Cybulska et al. PROGRESS IN CARDIOVASCULAR DISEASES
- Statins and LDL-C in Secondary Prevention—So Much Progress, So Far to Go
- (2020) Maciej Banach et al. JAMA Network Open
- Safety and Efficacy of Bempedoic Acid to Reduce LDL Cholesterol
- (2019) Kausik K. Ray et al. NEW ENGLAND JOURNAL OF MEDICINE
- Mendelian Randomization Study of ACLY and Cardiovascular Disease
- (2019) Brian A. Ference et al. NEW ENGLAND JOURNAL OF MEDICINE
- Bempedoic acid plus ezetimibe fixed-dose combination in patients with hypercholesterolemia and high CVD risk treated with maximally tolerated statin therapy
- (2019) Christie M Ballantyne et al. European Journal of Preventive Cardiology
- Effect of Simvastatin-Ezetimibe Compared With Simvastatin Monotherapy After Acute Coronary Syndrome Among Patients 75 Years or Older
- (2019) Richard G. Bach et al. JAMA Cardiology
- P705Step by step diagnosis and management of statin intolerance: position paper from an international lipid expert panel
- (2019) P Penson et al. EUROPEAN HEART JOURNAL
- Inclisiran—New hope in the management of lipid disorders?
- (2019) Krzysztof Dyrbuś et al. Journal of Clinical Lipidology
- Management of Statin Intolerance in 2018: Still More Questions Than Answers
- (2018) Peter P. Toth et al. American Journal of Cardiovascular Drugs
- Effects of vitamin D supplementation on adherence to and persistence with long-term statin therapy: Secondary analysis from the randomized, double-blind, placebo-controlled ViDA study
- (2018) Zhenqiang Wu et al. ATHEROSCLEROSIS
- Efficacy and safety of bempedoic acid added to ezetimibe in statin-intolerant patients with hypercholesterolemia: A randomized, placebo-controlled study
- (2018) Christie M. Ballantyne et al. ATHEROSCLEROSIS
- Should heart age calculators be used alongside absolute cardiovascular disease risk assessment?
- (2018) Carissa Bonner et al. BMC Cardiovascular Disorders
- Statin Intolerance
- (2018) Maciej Banach et al. CARDIOLOGY CLINICS
- Effect of Ezetimibe Monotherapy on Plasma Lipoprotein(a) Concentrations in Patients with Primary Hypercholesterolemia: A Systematic Review and Meta-Analysis of Randomized Controlled Trials
- (2018) Kamal Awad et al. DRUGS
- Adverse effects of statin therapy: perception vs. the evidence – focus on glucose homeostasis, cognitive, renal and hepatic function, haemorrhagic stroke and cataract
- (2018) François Mach et al. EUROPEAN HEART JOURNAL
- The Role of Nutraceuticals in Statin Intolerant Patients
- (2018) Maciej Banach et al. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY
- What have we learned about lipids and cardiovascular risk from PCSK9 inhibitor outcomes trials?
- (2018) Maciej Banach et al. CARDIOVASCULAR RESEARCH
- Alirocumab and Cardiovascular Outcomes after Acute Coronary Syndrome
- (2018) Gregory G. Schwartz et al. NEW ENGLAND JOURNAL OF MEDICINE
- Introducing the ‘Drucebo’ effect in statin therapy: a systematic review of studies comparing reported rates of statin-associated muscle symptoms, under blinded and open-label conditions
- (2018) Peter E. Penson et al. Journal of Cachexia Sarcopenia and Muscle
- Reduction of low density lipoprotein-cholesterol and cardiovascular events with proprotein convertase subtilisin-kexin type 9 (PCSK9) inhibitors and statins: an analysis of FOURIER, SPIRE, and the Cholesterol Treatment Trialists Collaboration
- (2017) Brian A Ference et al. EUROPEAN HEART JOURNAL
- Evaluating bempedoic acid for the treatment of hyperlipidaemia
- (2017) Peter Penson et al. EXPERT OPINION ON INVESTIGATIONAL DRUGS
- Cholesterol auxotrophy and intolerance to ezetimibe in mice with SREBP-2 deficiency in the intestine
- (2017) Shunxing Rong et al. JOURNAL OF LIPID RESEARCH
- Statin Intolerance and Risk of Coronary Heart Events and All-Cause Mortality Following Myocardial Infarction
- (2017) Maria-Corina Serban et al. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY
- Optimizing Cholesterol Treatment in Patients With Muscle Complaints
- (2017) Robert S. Rosenson et al. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY
- Evolocumab and Clinical Outcomes in Patients with Cardiovascular Disease
- (2017) Marc S. Sabatine et al. NEW ENGLAND JOURNAL OF MEDICINE
- Inclisiran in Patients at High Cardiovascular Risk with Elevated LDL Cholesterol
- (2017) Kausik K. Ray et al. NEW ENGLAND JOURNAL OF MEDICINE
- Effect of ETC-1002 on Serum Low-Density Lipoprotein Cholesterol in Hypercholesterolemic Patients Receiving Statin Therapy
- (2016) Christie M. Ballantyne et al. AMERICAN JOURNAL OF CARDIOLOGY
- Molecular mechanisms of statin intolerance
- (2016) Anna Gluba-Brzozka et al. Archives of Medical Science
- Diagnosis, Prevention, and Management of Statin Adverse Effects and Intolerance: Canadian Consensus Working Group Update (2016)
- (2016) G.B. John Mancini et al. CANADIAN JOURNAL OF CARDIOLOGY
- Statin-associated muscle symptoms: position paper from the Luso-Latin American Consortium
- (2016) Andrei C. Sposito et al. CURRENT MEDICAL RESEARCH AND OPINION
- IMPROVE-IT
- (2016) Maciej Banach et al. CURRENT OPINION IN CARDIOLOGY
- Statin non-adherence and residual cardiovascular risk: There is need for substantial improvement
- (2016) Maciej Banach et al. INTERNATIONAL JOURNAL OF CARDIOLOGY
- Efficacy and Tolerability of Evolocumab vs Ezetimibe in Patients With Muscle-Related Statin Intolerance
- (2016) Steven E. Nissen et al. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- Treatment with ETC-1002 alone and in combination with ezetimibe lowers LDL cholesterol in hypercholesterolemic patients with or without statin intolerance
- (2016) Paul D. Thompson et al. Journal of Clinical Lipidology
- Statin-Associated Side Effects
- (2016) Paul D. Thompson et al. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY
- Interpretation of the evidence for the efficacy and safety of statin therapy
- (2016) Rory Collins et al. LANCET
- Hepatotoxicity of statins and other lipid-lowering agents
- (2016) Einar S. Björnsson LIVER INTERNATIONAL
- Liver-specific ATP-citrate lyase inhibition by bempedoic acid decreases LDL-C and attenuates atherosclerosis
- (2016) Stephen L. Pinkosky et al. Nature Communications
- Discussion around statin discontinuation in older adults and patients with wasting diseases
- (2016) Maciej Banach et al. Journal of Cachexia Sarcopenia and Muscle
- Lipid-lowering efficacy of the PCSK9 inhibitor evolocumab (AMG 145) in patients with type 2 diabetes: a meta-analysis of individual patient data
- (2016) Naveed Sattar et al. Lancet Diabetes & Endocrinology
- Position paper Statin intolerance – an attempt at a unified definition. Position paper from an International Lipid Expert Panel
- (2015) Maciej Banach et al. Archives of Medical Science
- Vitamin D status modifies the association between statin use and musculoskeletal pain: A population based study
- (2015) Travis Y. Morioka et al. ATHEROSCLEROSIS
- Genetic and immunologic susceptibility to statin-related myopathy
- (2015) Jaideep Patel et al. ATHEROSCLEROSIS
- Impact of statin therapy on coronary plaque composition: a systematic review and meta-analysis of virtual histology intravascular ultrasound studies
- (2015) Maciej Banach et al. BMC Medicine
- Adverse Effects of Statins - Myths and Reality
- (2015) Iveta Simic et al. CURRENT PHARMACEUTICAL DESIGN
- Statin-associated muscle symptoms: impact on statin therapy—European Atherosclerosis Society Consensus Panel Statement on Assessment, Aetiology and Management
- (2015) Erik S. Stroes et al. EUROPEAN HEART JOURNAL
- Analysis of vitamin D levels in patients with and without statin-associated myalgia — A systematic review and meta-analysis of 7 studies with 2420 patients
- (2015) Marta Michalska-Kasiczak et al. INTERNATIONAL JOURNAL OF CARDIOLOGY
- Use of ETC-1002 to treat hypercholesterolemia in patients with statin intolerance
- (2015) Paul D. Thompson et al. Journal of Clinical Lipidology
- Efficacy and safety of alirocumab vs ezetimibe in statin-intolerant patients, with a statin rechallenge arm: The ODYSSEY ALTERNATIVE randomized trial
- (2015) Patrick M. Moriarty et al. Journal of Clinical Lipidology
- Visit-to-Visit Low-Density Lipoprotein Cholesterol Variability and Risk of Cardiovascular Outcomes
- (2015) Sripal Bangalore et al. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY
- Ezetimibe Added to Statin Therapy after Acute Coronary Syndromes
- (2015) Christopher P. Cannon et al. NEW ENGLAND JOURNAL OF MEDICINE
- Efficacy and Safety of ETC-1002, a Novel Investigational Low-Density Lipoprotein-Cholesterol–Lowering Therapy for the Treatment of Patients With Hypercholesterolemia and Type 2 Diabetes Mellitus
- (2014) Maria J. Gutierrez et al. ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY
- Low Vitamin D as a Risk Factor for the Development of Myalgia in Patients Taking High-Dose Simvastatin: A Retrospective Review
- (2014) Kari Mergenhagen et al. CLINICAL THERAPEUTICS
- Efficacy and safety of evolocumab (AMG 145), a fully human monoclonal antibody to PCSK9, in hyperlipidaemic patients on various background lipid therapies: pooled analysis of 1359 patients in four phase 2 trials
- (2014) E. A. Stein et al. EUROPEAN HEART JOURNAL
- Spectrum of statin hepatotoxicity: Experience of the drug-induced liver injury network
- (2014) Mark W. Russo et al. HEPATOLOGY
- An assessment by the Statin Muscle Safety Task Force: 2014 update
- (2014) Robert S. Rosenson et al. Journal of Clinical Lipidology
- National Lipid Association recommendations for patient-centered management of dyslipidemia: Part 1 – executive summary
- (2014) Terry A. Jacobson et al. Journal of Clinical Lipidology
- Lipid lowering with PCSK9 inhibitors
- (2014) Razvan T. Dadu et al. Nature Reviews Cardiology
- Resistance and intolerance to statins
- (2014) Ž. Reiner NUTRITION METABOLISM AND CARDIOVASCULAR DISEASES
- Discontinuation of Statins in Routine Care Settings
- (2013) Huabing Zhang et al. ANNALS OF INTERNAL MEDICINE
- Efficacy and Safety of a Novel Dual Modulator of Adenosine Triphosphate-Citrate Lyase and Adenosine Monophosphate-Activated Protein Kinase in Patients With Hypercholesterolemia
- (2013) Christie M. Ballantyne et al. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY
- Statins in the primary prevention of cardiovascular disease
- (2013) Željko Reiner Nature Reviews Cardiology
- An International Model to Predict Recurrent Cardiovascular Disease
- (2012) Peter W.F. Wilson et al. AMERICAN JOURNAL OF MEDICINE
- Effect of Statins on Skeletal Muscle Function
- (2012) Beth A. Parker et al. CIRCULATION
- Understanding Statin Use in America and Gaps in Patient Education (USAGE): An internet-based survey of 10,138 current and former statin users
- (2012) Jerome D. Cohen et al. Journal of Clinical Lipidology
- Cardiovascular benefits and diabetes risks of statin therapy in primary prevention: an analysis from the JUPITER trial
- (2012) Paul M Ridker et al. LANCET
- Co-administration of statins with cytochrome P450 3A4 inhibitors in a UK primary care population
- (2012) Ameet Bakhai et al. PHARMACOEPIDEMIOLOGY AND DRUG SAFETY
- Risk of Incident Diabetes With Intensive-Dose Compared With Moderate-Dose Statin Therapy
- (2011) David Preiss JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- Defining and Setting National Goals for Cardiovascular Health Promotion and Disease Reduction
- (2010) Donald M. Lloyd-Jones et al. CIRCULATION
- Rebound inflammatory response during the acute phase of myocardial infarction after simvastatin withdrawal
- (2009) Andrei C. Sposito et al. ATHEROSCLEROSIS
- Efficacy of Rosuvastatin (5 mg and 10 mg) Twice a Week in Patients Intolerant to Daily Statins
- (2008) Mamatha Gadarla et al. AMERICAN JOURNAL OF CARDIOLOGY
- Ezetimibe monotherapy for cholesterol lowering in 2,722 people: systematic review and meta-analysis of randomized controlled trials
- (2008) A. Pandor et al. JOURNAL OF INTERNAL MEDICINE
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationAdd your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload Now